Immunogenicity of three Haemophilus influenzae type b protein conjugate vaccines in HIV seropositive adults and analysis of predictors of vaccine response

By Dockrell D.H.   Poland G.A.   Steckelberg J.M.   Wollan P.C.   Strickland S.R.   Pomeroy C.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2779-2785

Elsevier

Access to resources Recommend Favorite

Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM 197 conjugate vaccines

By Bolgiano B.   Mawas F.   Yost S.E.   Crane D.T.   Lemercinier X.   Corbel M.J.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3189-3200

Elsevier

Access to resources Recommend Favorite

Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines

By Plumb J.E.   Yost S.E.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 399-404

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of Haemophilus influenzae type b polysaccharide-Neisseria meningitidis conjugate vaccine in 7.5 g liquid formulation: a comparison of three lots with the 15.0 g lyophilized formulation

By Study Group for 7.5  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 775-781

Elsevier

Access to resources Recommend Favorite

Antibody responses of three Haemophilus influenzae type b conjugate vaccines after one, two and three doses in Filipino children

By Capeding M.R.Z.   Nohynek H.   Kayhty H.   Pascual L.G.   Sunico E.S.   Tamundong A.A.   Ruutu P.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 1004-1008

Elsevier

Access to resources Recommend Favorite